Evidence map›Paper›PMID 40390483›Full record

ArticleJournal, genetic engineering & biotechnology2025

What's in (y)our food? - Occurrence of GM-containing foods on the Nigerian market and compliance with national regulations.

Josephine Amedu, Adedapo Adediji, Ngozi Miracle, Albert Anthony, Precious Adeyemi, Rabi Ahmed, Stephen Atsumbe, Mike Costly, Ayodele Majekodunmi, Odunayo Balogun and 6 more

Abstract read
In one paragraph

Article in Journal, genetic engineering & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Josephine AmeduNational Biosafety Management Agency, Abuja, Nigeria.
Adedapo AdedijiPan African University Life and Earth Sciences Institute, Ibadan, Nigeria; Inqaba Biotec, Ibadan, Nigeria. Electronic address: adedapo.adediji@gmail.com.
Ngozi MiracleNational Biosafety Management Agency, Abuja, Nigeria.
Albert AnthonyNational Biosafety Management Agency, Abuja, Nigeria.
Precious AdeyemiNational Biosafety Management Agency, Abuja, Nigeria.
Rabi AhmedNational Biosafety Management Agency, Abuja, Nigeria.
Stephen AtsumbeNational Biosafety Management Agency, Abuja, Nigeria.
Mike CostlyNational Biosafety Management Agency, Abuja, Nigeria.
Ayodele MajekodunmiFood and Agriculture Organization of the United Nations, Abuja, Nigeria.
Odunayo BalogunInqaba Biotec, Ibadan, Nigeria.
Oyewumi AkinpeluInqaba Biotec, Ibadan, Nigeria.
Kilsi BorgbaraInqaba Biotec, Ibadan, Nigeria.
Olanrewaju OlufowobiInqaba Biotec, Ibadan, Nigeria.
Hauwa Jibo TahirNational Biosafety Management Agency, Abuja, Nigeria.
Lukman AroworamimoInqaba Biotec, Ibadan, Nigeria. Electronic address: lukman.aroworamimo@inqababiotec.africa.
Agnes AsagbraNational Biosafety Management Agency, Abuja, Nigeria. Electronic address: aeasagbra@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The regulation of genetically modified (GM) food products in several jurisdictions considers appropriate labelling to be a key requirement for food safety and to ensure the protection of consumer choices. In Nigeria, such regulations are enforced by relevant government agencies. There is, however, little information on compliance levels with appropriate labeling regimes of GM products in Nigeria. This study was conducted to ascertain compliance with existing labeling guidelines and regulations for GM food products sampled from Abuja, Nigeria. DNA-based real-time polymerase chain reaction detection procedures were used to evaluate 15 processed and semi-processed pre-packaged food products obtained from retail stores in Abuja for the presence of specific regulatory sequences specific to GM products. Three regions present in GM food products were targeted, namely, the 35S promoter gene from cauliflower mosaic virus and figwort mosaic virus, with the nopaline synthase terminator from Agrobacterium tumefaciens. Eleven out of the 15 samples showed positive amplification for at least one regulatory sequence signature unique to GMOs, out of which only two were appropriately labeled as required by regulation. While the safety of GM products is a prerequisite for commercialization, labelling is required to protect consumer preference. The roles of relevant government agencies in developing appropriate labeling guidelines and enforcing the same to protect consumers' choices are discussed.

Indexed as

Cereal productsConsumer choiceFood safetyNAFDAC registration

Identifiers

PMID40390483
PMCPMC11987604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.